China Diagnostic Reagent Industry Analysis Report 2015

Research on China Diagnostic Reagent Industry, 2015 report is the latest addition to RnRMarketResearch.com industry research reports collection. The report is about 160 pages and provides Data Charts; the report is published in May -2015.

In-depth analysis of Diagnostic Reagent Industry in China, 2015 Report. After 30 years of development, the China's diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China's diagnostic reagent market comes from hospitals.

Complete report available on http://www.rnrmarketresearch.com/research-on-china-diagnostic-reagent-industry-2015-market-report.html

There's still a huge growth potential in China's diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China's diagnostic reagent market in 2014, especially in high-end fields. The market share of domestic enterprises mainly comes from biochemical reagents.

Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392985 (Single User License - US $2700)

China has fulfilled the import substitution of biochemical reagents, intensified competition has largely squeezed the profits in this subfield. Chemiluminescence Immunoassay (CLIA) and molecular diagnosis will be the most promising subfields in China's diagnostic reagent industry.

New Industries Biomedical Engineering Co., Ltd is the leading CLIA enterprise in China. Currently the company owns 102 chemiluminescent reagents and 8 models of CLIA analyzer. The...